6-APB/Summary
Harm potential 
-
- Moderately addictive with a high potential for abuse
- Exact toxic dosage is unknown
Tolerance 
-
- Full tolerance is reached with prolonged and repeated use
- Decreases to half after 3-4 weeks
- Returns to baseline after 6-8 weeks
- Cross-tolerance with all dopaminergic stimulants
Dangerous interactions
-
- !
- !((
- !/doc
- ((
- ))
- ))!
- -
- -3Cspan class="smw-highlighter" data-type="4" data-state="inline" data-title="Error" title="The wikipage input value is empty (e.g. SomeProperty::
- 0
- 0.5
- 0reilly
- 1
- 1,4-Butanediol
- 1,4-Butanediol
- 1,4-Butanediol
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- 1,4-Butanediol/Summary
- ... further results
-O-Desmethyltramadol.svg)
-Tramadol.svg)
-Tilidine.svg)
-Tilidine.svg)
-O-Desmethyltramadol.svg)
-Tramadol.svg)
-2--(2S,3S)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-_octahydroindolo-3,2-h-quinolizin-2-yl--3-_methoxyprop-2-enoic_acid_methyl_ester.png)
-1-Phenyl-N-propylpentan-2-amine.svg)
-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo-3,4-b-pyrazin-5-yl_4-methylpiperazine-1-carboxylate.png)
-1-(1,2-Diphenylethyl)piperidine.png)
-3-Ethyl-1,2,3,4,6,7,7a,12b-octahydro-7a-hydroxy-8-methoxy-%CE%B1-(methoxymethylene)indolo-2,3-a-quinolizine-2-acetic_acid_methyl_ester.png)
Visual effects 
-
- Geometry: Eventually leads to level 8A geometry
Cognitive effects 
-
- Anxiety
- Creativity enhancement
- Dream potentiation
- Emotion enhancement
- Empathy, affection and sociability enhancement
- Focus enhancement
- Immersion enhancement
- Increased libido
- Increased music appreciation
- Increased sense of humor
- Irritability
- Motivation enhancement
- Novelty enhancement
- Personal meaning enhancement
- Thought acceleration
- Wakefulness
